Skip to playerSkip to main content
  • 5 months ago
Senior IPS officer Satish Golcha was on Thursday appointed as the new Commissioner of Police of Delhi, a day after Chief Minister Rekha Gupta was assaulted during a public hearing.

Category

ЁЯЧЮ
News
Transcript
00:00all right from that let's cut across to some more breaking news coming in Delhi police commissioner
00:11has been shunted out top cop SBK Singh has been removed after the CM attack Satish Golcha has
00:18been appointed as the new CP for Delhi he's a 1992 batch IPS officer in the national capital
00:26so heads have finally rolled in the case of an attack that took place on Chief Minister
00:33Rikha Gupta just yesterday questions were being asked here on five live we had asked this question
00:39as well on what will happen where does the buck stop why wasn't proper security measures kept in
00:45place and here you go not just the joint CP not just the area DCP but the Delhi police commissioner
00:53has been shunted out altogether this is a big step this is a big move and perhaps a messaging going
01:01out from the home ministry on what lies ahead and that this will not be tolerated Satish Golcha now
01:08the new chief of Delhi police the police commissioner they're taking charge
01:15the dream wedding has turned into a brutal nightmare for the 26 year old woman all in the name of beauty
01:29in Ghaziabad a young bride says she was tortured to match the perfect body ideal body and was forced to
01:37do extreme workouts work out for three hours a day and star is she failed to do that why because the
01:44husband wanted her to have the figure of Nora Fateh Ali Khan a 26 year old bride in Ghaziabad near Delhi
01:54thought she was stepping into a dream marriage her family spent 77 lakh rupees in dowry including a
02:02Mahindra Scorpio 16 lakh rupees in jewelry and 10 lakh rupees in cash but what began as a new beginning
02:09soon turned into a nightmare Shanu claims she was forced to work out for three hours daily to meet
02:17her husband's unrealistic expectations of a Nora Fatehi like body failure to do so meant being denied food
02:25for days she alleges constant physical abuse from her husband who she accuses of watching inappropriate
02:32videos and being unfaithful the abuse escalated when Shanu discovered she was pregnant instead of support
02:40she was forced to take an abortion pill by her sister-in-law she soon suffered a miscarriage
02:47in June Shanu's parents took her away after years of torture since then her in-laws have allegedly
02:54threatened her with a divorce and refused to allow her to return a near impossible weight loss saga and
03:01horrifying turn to a marriage is the obsession with the perfect feminine figure getting deadly turn
03:09Bureau report India today the extent to which people go to get that ideal body or perhaps in
03:18the pursuit of one it's all for weight loss it's all for how you look now onto the big health story
03:24we are tracking today India's on the edge of a weight loss breakthrough anti-obesity drugs like
03:30semaglutide currently a luxury only for the ultra rich could soon cost less than your daily coffee from
03:373,000 rupees a month to just three 30,000 rupees a month beg your pardon to just 3,000 this could open
03:45floodgates for millions struggling with weight loss but also open floodgates for misuse so is this
03:51really a miracle fix or just the start of another health trap the next explainer takes you through all of that
03:57pharmaceutical giants are getting up to flood the market with affordable generics 2026 is expected to
04:14mark not just the arrival of the next generation of weight loss medication but the beginning of a
04:20nationwide health transformation but is this transformation entirely welcome and are we prepared
04:28for what it brings but first let's understand why now
04:33globally GLP one drugs like ozempic we go we have already helped nearly 20 million people lose weight since
04:472021 but in India access has been painfully slow and painfully expensive until now the core ingredient
04:57in these blockbuster drugs it's called semaglutide is going off patent in 2026 not just in India but in
05:05over 80 countries including Canada China Brazil and Saudi Arabia now what that means is once it happens
05:13prices are expected to fall hard by as much as 85 to 90 percent that means what once cost you about 20
05:23to 30,000 rupees a month could soon be available at just 2,500 to 4,000 a month this will be a
05:32fundamental shift in who gets to access obesity care we are talking about weight loss drugs from elite
05:40clinics in metros and putting them in the hands of everyday Indians with nearly 33 percent of Indian
05:48adults struggling with obesity this could have a massive public health impact but with mass access
05:55comes a set of new concerns while the promise of affordable treatment is exciting doctors are urging caution
06:03India's leading endocrinologist dr. Amrish Mittal says and I quote whenever prices go down it always
06:12helps our patients I assume the quality checks will be maintained as genetics enter the challenge of
06:18course is that misuse will become easier misuse might already be happening and it could further increase
06:25but overall I think the benefits outweigh the challenges I'm quite optimistic about this move
06:32the issue of misuse is a valid one a concerning one and to handle this misuse countries like Portugal
06:41have given only doctors with approved specialities permits to prescribe these drugs as a way of
06:48controlling it something the doctors in India are now exploring Padbushri Dr. Shashank Joshi who has
06:56been at the forefront of diabetes and obesity care in India says and I quote if and when the drugs become
07:03more affordable it will have a clear impact on the entire spectrum of more than 200 conditions which are
07:10impacted with people living with obesity the cosmetic use and the misuse of label needs to be contained
07:18because these drugs have compelling data on complications and even comorbidities must be given
07:25under expert supervision so it's clear there is a genuine sounding of caution but there is also a flip
07:34side to the generic race for weight loss drugs with patrons expiring the doors will wide open to Indian
07:41pharma players to jump in and they are wasting no time over 10 Indian companies have already filed for
07:47clinical trials mostly for oral versions of semaglutide meaning injections won't be required anymore add to
07:56that the competition from Chinese manufacturers and what you get is a perfect storm of falling prices but
08:04remember this isn't just a drug story the ripple effects across the healthcare ecosystem could be
08:11enormous for example insurers may begin covering weight loss therapies hospitals may roll out dedicated
08:18obesity programs startups are already building subscription-based models that combine medication
08:24coaching and lifestyle tracking what this means in conclusion what does this mean for you and me what
08:33once costed 30,000 a month treatment is set to drop to 3,000 or less that's a game changer not just for
08:41individuals but for India's public health system 2025 has already seen early entry of next gen weight loss drugs into the
08:49Indian market 2026 will be the year they go mainstream but if we want this revolution to truly succeed we need
09:00more than cheaper drugs we need education regulation and ethical oversight because if we are not careful India
09:09could end up facing the same problems the West is already struggling with from overuse and side effects to
09:16social media fueled obsession and that's not the kind of healthcare transformation anyone wants
09:23Sonal Mirotra Kapoor for India today
09:25all right so that's what's coming it's on the horizon in 2026 but here are the big five questions that you
09:35need to ask yourself and that we will be taking to our guests now can India prevent these drugs from
09:42becoming a cosmetic shortcut for the rich and for the team now do GLP one drugs clause blindness has has
09:50been the case reported by several in United States are GLP one drugs linked to thyroid cancer do they lead to
09:58stomach paralysis as has been said in a lawsuit that has been filed against Ozempic should doctors now
10:07prescribe GLP one drugs for weight alone or wait for the co-morbidities these very important five
10:14questions is what we're going to pick up with our guests this evening joining us now is a professor and
10:20dr. Shashank Joshi endocrinologist one of the most respected people on the subject in the country also with
10:26us is dr. Wade he's a chief scientific advisor at fitter dr. Joshi let me begin with you as i said in that report
10:34as well it's great from a medical perspective it's perhaps very worrying from a societal perspective in
10:44your view once these drugs get cheaper more accessible not injectables but just a pill like you pop like so many
10:51take for diabetes or blood pressure or blood thinners for that people take what is the downside really
10:58and how do we ensure that the misuse is actually curved well i think you get out a very important
11:06point the main thing is that obesity is a disease and because it's a disease we need to be very cautious
11:13about use of these drugs because they should be only given under ethical prescription by an endocrinologist
11:20or an expert in that domain like a cardiologist or a physician who has domain expertise in giving
11:26this drug and not by any any person so that is the first thing secondly there are compelling uses for
11:32these drugs like diabetes heart disease with a bmi more than 27 or 30. so the most deserving people
11:39who are sick they deserve it the most because it can save lives it can save them from heart disease etc so
11:45i think it is a very important thing that these are not cosmetic medications and they are already
11:51accessible and affordable now in india the oral pill of sapatutite virgin costs only 10 000 rupees a month
11:57compared to say the injectable which is 13 to 15 000 or 20 000 rupees a month so they are getting more
12:02and more affordable and once the genericization will happen it will be more accessible but they have to
12:08be medically supervised so let me be very clear that there are known contraindications they need medical
12:13supervision and they should not be given by all and unless and until yeah but dr joshi that's the hope
12:20no we do know and you also understand this more than anybody else that misuse is happening even now
12:27when i speak with endocrinologists across the country they tell you that every second person walking
12:33into their clinic as of today is asking for it when they don't need it if that's the case now when they
12:39are relatively expensive how are you saying we'll curve it once they become so much cheaper i think you
12:47will need ethical oversight and ethical all right we'll just fix that line with dr joshi just a bit let me
13:00bring in dr wade now dr wade you've read uh you've written a detailed article where you talk about
13:07the downside of these drugs you talk about warning signs uh would you like to make your opening
13:15statement on why you think people who just want to fit into that sari or just want to fit into that
13:22pair of jeans or just that get that body to go to a beach should stay away from it
13:31yes so first of all these drugs were primarily developed for diabetes
13:36and they have found its use in weight loss so that is first so when it comes to weight loss we
13:41are talking about obesity so if we take a step back and look at obesity as a problem
13:46so obesity also comes typically happens with advanced age and diabetes is is a co-morbidity i mean
13:56they do have the license to be prescribed for weight loss in india at least the ones that are operating
14:01they have the license it's not like doctors are giving it for weight loss under the table
14:07they have the license to be prescribed for diabetes and they have the license to be prescribed for
14:10weight loss yes they have the license there is no uh debate on that but but how it has been marketed
14:18that this is the magic pill so the real intervention if you think about it why has why there is obesity in
14:24the first place why there is diabetes in the first place that is because of lack of exercise so if you
14:30look at the cause of why this is happening it is because it's happening because of lack of exercise
14:35that is point number one secondly even for these drugs to work better caloric restriction is required
14:41and resistance training required because one of the side effects of these drugs among cancer and other
14:47things is muscle loss so if you have an adequate nutrient dense uh calorie deficit diet primarily a
14:54sufficient protein intake and complement that with resistance training then these drugs are known to
15:00perform better but what is happening is that this complete information is not going out and just that
15:06these drugs are looked upon as magic pill which is something is is something that one should be uh uh uh
15:13wary about i'm very happy you brought that point that this drug alone fixing your health is the wrong or
15:22perhaps the incomplete information going out we were just showing and we'd love to go back to those
15:27pictures of before and after of celebrities the celebrities who've gone on record to say that they
15:33lost a lot of weight and they were struggling with it for a while thanks to glp one oprah winfrey one of
15:39the most influential women or perhaps human being on the planet has gone ahead to say that she was
15:44struggling with it for so long and there's finally uh you know rescue of sorts that she has so you have
15:50celebrities all over saying that i managed to fix my health with it it's going to be very difficult to
15:56expect the common man to do the research which is why i ask you a very pointed question uh glp one drugs
16:03causing blindness glp one drugs causing thyroid cancer causing stomach paralysis what exactly is your
16:12research saying on these three points there is definitely enough research done on this point
16:18stating that these are the known side effects in fact if you look at the websites and official
16:24websites of the company that market this drug they do mention about these side effects clearly
16:28and people having certain family history of cancers uh are advised to definitely consult their
16:34physicians and in any which ways this drug should always taken and be taken under medical uh medical
16:41guidance that's right dr shashank joshi is also back with us dr joshi could you shed some light on the
16:48latest that we are hearing on glp one drugs in fact just this morning we read of a report a legal notice
16:54that has been sent to ozempic now off and it's a public suit in a way that it's a combined suit of
17:01several people who are saying that because of ozempic and if i understand the lawsuit correctly it says
17:08that prolonged use of the drug had caused blindness has caused stomach paralysis and even increased risk
17:17of thyroid cancer this case is now in a u.s court what exactly are use sort of reading from this in
17:27terms of prescriptions to be given out here in india so let us look at all the side effects of these
17:33agents the commonest side effects of these agents are nausea vomiting diarrhea and constipation these
17:39are given and we counsel all the patient that is why we start low and go slow and that is why there
17:44is a need if there is an underlying gallstone or a gallbladder disease or a pancreatic disease we do
17:49not give these drugs which is why medical supervision is necessary so these are something every drug which
17:55works has a effect has a side effect so these are something which are there in the pharmaceutical domain
18:00which have been published by the companies as far as multiple endocrine neoplasia is a very rare
18:05condition occasionally we do a calcitonin level and these are rare forms of familial thyroid cancers
18:11which i have had some association in animal studies but human data has not been forthcoming on these
18:16agents for sure as far as the blindness story is concerned i think the verdict is not out there are some
18:23data sets which are retrospective for it some against it but i think the final verdict on this is not out
18:29it's a very rare thing so remember a couple of things that nausea vomiting and diarrhea
18:34constipation are common side effects to the tune of five to ten percent and therefore we have to start
18:40slow the other side effects like a rare form of a familial thyroid cancer or blindness are subject to
18:47scrutiny and pharmacovigilance remember every drug on planet earth will have effects and side effects
18:52somewhere so dr joshi am i understanding you correctly you're saying there is nothing wrong
18:58with the drug these claims that are being spoken about these downside is known and perhaps the medical
19:03fraternity is aware about it why these cases are happening is because they have been misprescribed
19:10is that the right way to understand this so that i'm not so sure but people do not want see these drugs
19:17are very good to initiate and they have to stay on the medication for an appropriate period of time
19:22but remember a drug is not a substitute lifestyle so sonal i think the right thing is that we need to
19:28integrate lifestyle once you have lost weight and continue the lifestyle protein muscle mass building
19:34and also be pharmacovigilant for every adverse event i think if that is not done and people stick to it
19:41like the way they wear a shirt or a pant or our clothes i think that's not correct so i think
19:46there is a clear need for a medical oversight and a regulatory oversight both and i think we need
19:51more and more pharmacovigilance on the same so i think the verdict on blindness is still not out the
19:55verdict on thyroid cancer is still not clearly out the verdict on nausea vomiting constipation is very
20:01clear that it is very much there my last question very quickly dr joshi since i have you so are we
20:08saying that the responsibility of misuse of these drugs leading to this very lethal kind of side
20:14effects people going blind getting cancer getting stomach paralysis a lot of it is going to rely on
20:20the doctors and how they prescribe it absolutely but i think it will equally also lie on the people who
20:28are taking it and it is important to understand that it is a multi-disciplinary care when it comes to
20:33weight loss and people living with obesity uh have an option now they have a surgical option they have
20:39a medical option and they have a lifestyle option and we need to integrate care i don't think and
20:44that's why i really compliment our honorable prime minister for putting people living with obesity on
20:49spotlight and focus fit india movement and it's important to integrate lifestyle and medical supervision
20:55in the entire care ecosystem because i'm afraid that's all the time we have uh dr joshi dr wait thank
21:04you so much for joining us with your perspective this is clearly not the last you've heard of the story
21:09and clearly not here on five live with me as well all right but talking about ozempic let's talk about
21:14a trend that's emerging out of it what does ozempic actually do it kills your appetite reduces it so you
21:20end up eating less you end up losing a lot more weight in very simple ways of understanding that
21:27now restaurants have caught on to this trend and what are they presenting ozempic menus take a look
21:36are you going out every day but getting tired to eat well you're not alone people are in fact
21:42changing the way they're eating and restaurants globally are reporting that people are asking them
21:47to share appetizers share mains and even entirely skipping desserts well eating out is now becoming
21:54more about flavor and less about quantity eating out is also becoming more about variety and less
22:00about stuffing yourself with volume and that is where bite-sized meals come into picture
22:05as of may 2025 more than 12 percent of americans have used glp1 drugs for weight loss this is a trend
22:22that is mirroring in london and dubai food capitals outside of new york the medications reduce appetite and
22:29mimic the feeling of being full in manhattan a range of restaurants are now introducing ozempic
22:34menus or skinny jab menus to cater to the growing need for bite-sized food
22:45india is also becoming more image and health conscious than ever before people are cutting
22:50back on drinking when they don't feel it and are not embarrassed to order small portions and prioritize
22:55feeling good post meal this is not a challenge but an opportunity for restaurants as a bite-sized
23:02dessert is still better than no dessert at all but with all this food is your tummy still rumbling
23:09well shrinking portions may not exactly mean shrinking bills and that is up for debate but one thing is
23:16for sure hospitality is no longer a one-size-fits-all solution and shrinking portions are just the new normal
23:23with sriya shrivasav and video journalist sachin chandok bureau report india today
Comments

Recommended